Clayton W. Beard

2.3k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

Clayton W. Beard is a scholar working on Molecular Biology, Genetics and Agronomy and Crop Science. According to data from OpenAlex, Clayton W. Beard has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Agronomy and Crop Science. Recurrent topics in Clayton W. Beard's work include Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and RNA and protein synthesis mechanisms (7 papers). Clayton W. Beard is often cited by papers focused on Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and RNA and protein synthesis mechanisms (7 papers). Clayton W. Beard collaborates with scholars based in United States, France and Chile. Clayton W. Beard's co-authors include Peter W. Mason, Armin Hekele, Andrew J. Geall, Susan W. Barnett, Katherine R. Spindler, Jeffrey B. Ulmer, Gillis R. Otten, Christine A. Shaw, Ayush Verma and Thomas Krucker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Molecular Biology.

In The Last Decade

Clayton W. Beard

28 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonviral delivery of self-amplifying RNA vaccines

2012 525 citations Andrew J. Geall, Gillis R. Otten et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clayton W. Beard United States	20	911	389	359	339	322	30	1.6k
Verónica Martı́n Spain	24	648 0.7×	518 1.3×	235 0.7×	660 1.9×	148 0.5×	64	1.9k
David Steffen United States	22	297 0.3×	270 0.7×	226 0.6×	453 1.3×	227 0.7×	88	1.4k
Neeraja Idamakanti United States	23	925 1.0×	1.2k 3.1×	97 0.3×	518 1.5×	208 0.6×	38	1.7k
Gregory J. Tobin United States	21	517 0.6×	239 0.6×	346 1.0×	226 0.7×	94 0.3×	49	1.3k
Karen V. Kibler United States	22	671 0.7×	212 0.5×	772 2.2×	225 0.7×	86 0.3×	44	1.9k
Krystyna Bieńkowska-Szewczyk Poland	22	500 0.5×	200 0.5×	292 0.8×	222 0.7×	134 0.4×	61	1.5k
Andrea Cimarelli France	28	968 1.1×	389 1.0×	1.0k 2.9×	813 2.4×	113 0.4×	75	2.6k
Elena Y. Dobrikova United States	24	708 0.8×	422 1.1×	310 0.9×	291 0.9×	339 1.1×	45	1.5k
Ángel Ezquerra Spain	28	379 0.4×	399 1.0×	1.1k 3.0×	486 1.4×	150 0.5×	78	2.1k
Salvatore J. Arrigo United States	16	747 0.8×	294 0.8×	874 2.4×	928 2.7×	140 0.4×	27	2.4k

Countries citing papers authored by Clayton W. Beard

Since Specialization

Citations

This map shows the geographic impact of Clayton W. Beard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clayton W. Beard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clayton W. Beard more than expected).

Fields of papers citing papers by Clayton W. Beard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clayton W. Beard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clayton W. Beard. The network helps show where Clayton W. Beard may publish in the future.

Co-authorship network of co-authors of Clayton W. Beard

This figure shows the co-authorship network connecting the top 25 collaborators of Clayton W. Beard. A scholar is included among the top collaborators of Clayton W. Beard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clayton W. Beard. Clayton W. Beard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barsky, Sanford H., et al.. (2025). True cancer stem cells exhibit relative degrees of dormancy and genomic stability. Neoplasia. 60. 101127–101127.

Rouse, Jeremy, et al.. (2024). Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform. Molecular Therapy — Methods & Clinical Development. 32(3). 101320–101320. 1 indexed citations

Scott, David W., Christine Dos Santos, Marie‐Pierre Belot, et al.. (2021). Intravenous AAV5 Gene Therapy with Human CYP21A1 Corrects Phenotypic Deficiencies of the 21-Hydroxylase Kockout Mouse Model and Demonstrates Durability and Safety in Non-Human Primates and Mice. SPIRE - Sciences Po Institutional REpository.

Scott, David W., et al.. (2020). OR25-01 Durable CYP21A2 Gene Therapy in Non-Human Primates for Treatment of Congenital Adrenal Hyperplasia. Journal of the Endocrine Society. 4(Supplement_1). 6 indexed citations

Samsa, Marcelo M., Lesley C. Dupuy, Clayton W. Beard, et al.. (2019). Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice. Molecular Therapy. 27(4). 850–865. 51 indexed citations

MacLeod, Daniel T., Aaron J. Martin, Armin Hekele, et al.. (2017). Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells. Molecular Therapy. 25(4). 949–961. 223 indexed citations

Bell, Christie, Dong Yü, Christina D. Smolke, et al.. (2015). Control of alphavirus-based gene expression using engineered riboswitches. Virology. 483. 302–311. 37 indexed citations

Wen, Yingxia, James E. Monroe, Jacob Archer, et al.. (2014). Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine. 32(30). 3796–3804. 68 indexed citations

Maruggi, Giulietta, Christine A. Shaw, Gillis R. Otten, Peter W. Mason, & Clayton W. Beard. (2013). Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity. Virology. 447(1-2). 254–264. 10 indexed citations

10.

Jorquera, Patricia A., et al.. (2010). Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization. Vaccine. 28(18). 3238–3246. 23 indexed citations

11.

Penalva, Luiz O. F., Joseph M. Thompson, Laura White, et al.. (2007). A Two-Phase Innate Host Response to Alphavirus Infection Identified by mRNP-Tagging In Vivo. PLoS Pathogens. 3(12). e199–e199. 19 indexed citations

12.

Beard, Clayton W., Gordon B. Ward, Elizabeth Rieder, et al.. (1999). Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. Journal of Biotechnology. 73(2-3). 243–249. 61 indexed citations

13.

Beard, Clayton W. & Peter W. Mason. (1998). Out on the farm with DNA vaccines. Nature Biotechnology. 16(13). 1325–1328. 27 indexed citations

14.

Almeida, Márcia Rogéria de, Elizabeth Rieder, Jarasvech Chinsangaram, et al.. (1998). Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Research. 55(1). 49–60. 30 indexed citations

15.

Smith, Kimberley, Baoling Ying, Amy Oberhauser Ball, Clayton W. Beard, & Katherine R. Spindler. (1996). Interaction of Mouse Adenovirus Type 1 Early Region 1A Protein with Cellular Proteins pRb and p107. Virology. 224(1). 184–197. 28 indexed citations

16.

Beard, Clayton W. & Katherine R. Spindler. (1995). Characterization of an 11K Protein Produced by Early Region 3 of Mouse Adenovirus Type 1. Virology. 208(2). 457–466. 12 indexed citations

17.

Ball, Amy Oberhauser, Clayton W. Beard, Pedro Villegas, & Katherine R. Spindler. (1991). Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1. Virology. 180(1). 257–265. 27 indexed citations

18.

Beard, Clayton W., et al.. (1990). Transcription mapping of mouse adenovirus type 1 early region 3. Virology. 175(1). 81–90. 30 indexed citations

19.

Ball, Amy Oberhauser, Clayton W. Beard, Sambra D. Redick, & Katherine R. Spindler. (1989). Genome organization of mouse adenovirus type 1 early region 1: A novel transcription map. Virology. 170(2). 523–536. 30 indexed citations

20.

Geiduschek, E. Peter & Clayton W. Beard. (1978). Effect of the SP01 DNA-binding protein, TF1, on promoter competition. Journal of Molecular Biology. 126(3). 481–488. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact